| AJICAP: affinity peptide mediated regiodivergent functionalization of native antibodies K Yamada, N Shikida, K Shimbo, Y Ito, Z Khedri, Y Matsuda, ... Angewandte Chemie 131 (17), 5648-5653, 2019 | 103 | 2019 |
| An overview of process development for antibody-drug conjugates produced by chemical conjugation technology Y Matsuda, BA Mendelsohn Expert Opinion on Biological Therapy 21 (7), 963-975, 2021 | 52 | 2021 |
| Recent advances in drug–antibody ratio determination of antibody–drug conjugates Y Matsuda, BA Mendelsohn Chemical and Pharmaceutical Bulletin 69 (10), 976-983, 2021 | 38 | 2021 |
| Comparison of analytical methods for antibody–drug conjugates produced by chemical site-specific conjugation: first-generation AJICAP Y Matsuda, V Robles, MC Malinao, J Song, BA Mendelsohn Analytical chemistry 91 (20), 12724-12732, 2019 | 35 | 2019 |
| Current approaches for the purification of antibody–drug conjugates Y Matsuda Journal of Separation Science 45 (1), 27-37, 2022 | 34 | 2022 |
| A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First … Y Matsuda, M Leung, T Okuzumi, B Mendelsohn Antibodies 9 (2), 16, 2020 | 32 | 2020 |
| Gram-scale antibody–drug conjugate synthesis by site-specific chemical conjugation: AJICAP first generation Y Matsuda, K Yamada, T Okuzumi, BA Mendelsohn Organic Process Research & Development 23 (12), 2647-2654, 2019 | 31 | 2019 |
| Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation Y Matsuda, MC Malinao, V Robles, J Song, K Yamada, BA Mendelsohn Journal of Chromatography B 1140, 121981, 2020 | 30 | 2020 |
| Good manufacturing practice strategy for antibody–drug conjugate synthesis using site-specific chemical conjugation: first-generation AJICAP Y Matsuda, C Clancy, Z Tawfiq, V Robles, BA Mendelsohn ACS omega 4 (24), 20564-20570, 2019 | 29 | 2019 |
| AJICAP second generation: improved chemical site-specific conjugation technology for antibody–drug conjugate production T Fujii, Y Matsuda, T Seki, N Shikida, Y Iwai, Y Ooba, K Takahashi, ... Bioconjugate Chemistry 34 (4), 728-738, 2023 | 28 | 2023 |
| Synthesis and biological evaluation of antibody drug conjugates based on an antibody expression system: conamax Z Tawfiq, NC Caiazza, S Kambourakis, Y Matsuda, B Griffin, JC Lippmeier, ... ACS omega 5 (13), 7193-7200, 2020 | 28 | 2020 |
| Chemical site-specific conjugation platform to improve the pharmacokinetics and therapeutic index of Antibody–Drug conjugates Y Matsuda, T Seki, K Yamada, Y Ooba, K Takahashi, T Fujii, S Kawaguchi, ... Molecular Pharmaceutics 18 (11), 4058-4066, 2021 | 26 | 2021 |
| Analytical Comparison of Antibody-Drug Conjugates Based on Good Manufacturing Practice Strategies Z TAWFIQ, Y MATSUDA, MJ ALFONSO, C CLANCY, V ROBLES, ... Analytical Sciences, 19P465, 2020 | 26 | 2020 |
| Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation Technology Y Matsuda, M Kliman, BA Mendelsohn Journal of the American Society for Mass Spectrometry, 2020 | 26 | 2020 |
| Synthetic studies on polymaxenolides: synthesis and structure elucidation of nominal epoxyafricanane and other africane-type sesquiterpenoids Y Matsuda, Y Endo, Y Saikawa, M Nakata The Journal of Organic Chemistry 76 (15), 6258-6263, 2011 | 26 | 2011 |
| Insight into temperature dependency and design of experiments towards process development for cysteine‐based antibody‐drug conjugates Y Matsuda, Z Tawfiq, M Leung, BA Mendelsohn ChemistrySelect 5 (28), 8435-8439, 2020 | 25 | 2020 |
| Antibody–drug conjugate synthesis using continuous flow microreactor technology Y Nakahara, BA Mendelsohn, Y Matsuda Organic Process Research & Development 26 (9), 2766-2770, 2022 | 24 | 2022 |
| Chromatographic analysis of site-specific antibody-drug conjugates produced by AJICAP first-generation technology using a recombinant FcγIIIa receptor-ligand affinity column Y Matsuda, A Chakrabarti, K Takahashi, K Yamada, K Nakata, T Okuzumi, ... Journal of Chromatography B 1177, 122753, 2021 | 23 | 2021 |
| In-situ Reverse Phased HPLC Analysis of Intact Antibody-Drug Conjugates Y Matsuda, M Leung, Z Tawfiq, T Fujii, BA Mendelsohn Analytical Sciences 37 (8), 1171-1176, 2021 | 21 | 2021 |
| Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates T Fujii, C Reiling, C Quinn, M Kliman, BA Mendelsohn, Y Matsuda Exploration of Targeted Anti-tumor Therapy 2 (6), 576, 2021 | 19 | 2021 |
masaya nakatadepartment of applied chemistry, keio university在 keio.jp 的电子邮件经过验证
